Sunday, June 18, 2017 9:30:00 PM
EXCERPT FROM PR AS FOLLOWS:
MIAMI, FL--(Marketwired - May 4, 2017) - Omni Health, Inc., ( OTC PINK : OMHE ), a vertically integrated healthcare company dedicated to the development of pharmaceutical, anti-aging products, and cannabis biotech engineering, announced today the grand opening of its state of the art biotech R&D and manufacturing laboratory facility in Miami, Florida.
"Having our own biotechnology research facility with state of the art equipment and manufacturing capabilities is a game changer for our company and puts Omni Health in a completely different league," says Omni Health CEO, Andrey Soloviev. He went on to say, "We are now able to drastically accelerate our "concept to market" capability and to rapidly deploy new products on the market."
With a number of products in the curent pipeline to bring on board, Omni Health now has a competitive advantage of doing in-house research and development, with laser focus on product manufacturing and can enjoy better margins and returns over product costs.
"Technology, innovation and R&D will help drive our company forward and enable us to develop superior quality intellectual properties with rapid deployment to market and capitalize on over 40 years of business excellence while focusing on our core competencies," concluded Mr. Soloviev.
For more information on Omni Health, visit the company's new website at http://www.OmniHealth.md
"The stock market is a device for transferring money from the impatient to the patient" — Warren Buffett
"The Big Money is not in the buying and the selling but in the waiting" — Charlie Munger
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM